Same Indication

Memantine vs Nivolumab

Memantine vs Nivolumab: Overview

This comparison examines the pharmacological differences between Memantine and Nivolumab.

Mechanism of Action

Memantine: Non-competitive NMDA receptor antagonist.

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Memantine β€” 60-80 hours; Nivolumab β€” 27 days.

Chemical Properties

Molecular Formula: Memantine β€” C12H21N.

Molecular Weight: Memantine β€” 179.3080 g/mol.

Type: Memantine β€” Small molecule; Nivolumab β€” Antibody.